Discuss your research needs

Tell us the disease area, the priority markets and the decision in front of you. We read every inquiry ourselves and reply by email, usually with a few questions and a suggested scoping call.

• An initial conversation about the decision in front of you, not a sales pitch.
• A view on what a rare disease landscape, TPP validation or barrier and driver analysis would tell you.
• Scope, sequencing and the evidence we would need from your side.